OpenVSafe by OpenVAERS
Search V-safe

Q5Q-13025-44496

2 vaccinations 9 coded responses 19 check-ins 9 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
809 / CO
Registered
2021-09-18
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-09-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-09-18
    Registered in v-safe
  3. 2021-09-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal pain
    Adult check-in
  4. 2021-09-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue, Palpitations — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Heart burn?, heart palpitations, intense fatigue
    MedDRA releases: 2024-11 · check-in free text available
  5. 2021-09-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-09-24
    Health check-in — day 7, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  7. 2021-10-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-10-08
    Dose 2 — Pfizer-BioNTech
  9. 2021-10-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Chest pain
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-10-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Cough, Sneezing — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Coughing, sneezing, chest burning; past 3 days
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-10-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Stuffiness and running nose,
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-10-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Nasal congestion — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Stuffy nose, burning chest
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-10-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, chest burning
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-10-15
    Survey response — day 7, dose 2
    MedDRA: Rhinorrhoea — Feeling: Good · Fatigue or tiredness
    Free text: Sniffles
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-10-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-10-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-11-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-11-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-11-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-01-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-04-10
    Survey response — 6 months, dose 2
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activities
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-10-08
    Survey response — 12 months, dose 2
    MedDRA: Influenza like illness — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Flu like symptoms
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-09-17Pfizer-BioNTech No
22021-10-08Pfizer-BioNTech No

Free text

Release 9 — days 1–6 daily, dose 1

2021-09-19

Systemic reaction (other): Heart burn?, heart palpitations, intense fatigue

Release 10 — days 1–6 daily, dose 2

2021-10-10

Systemic reaction (other): Chest pain

2021-10-11

Systemic reaction (other): Coughing, sneezing, chest burning; past 3 days

2021-10-12

Systemic reaction (other): Stuffiness and running nose,

2021-10-13

Systemic reaction (other): Stuffy nose, burning chest

2021-10-14

Systemic reaction (other): Runny nose, chest burning

Release 10 — day 7, dose 2

2021-10-15

Systemic reaction (other): Sniffles

Release 11 — 6 months, dose 2

2022-04-10

Symptoms: Cold symptoms

Release 12 — 12 months, dose 2

2022-10-08

Symptoms: Flu like symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDInfluenza like illness · · ✓
SDNasopharyngitis · · ✓
SROChest pain · · ✓
SROCough · · ✓
SROFatigue · · ✓
SRONasal congestion · · ✓
SROPalpitations · · ✓
SRORhinorrhoea · · ✓
SROSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release